Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 4.22%
March 31, 2026 0.56%
December 31, 2025 6.38%
September 30, 2025 10.70%
June 30, 2025 10.07%
March 31, 2025 6.05%
December 31, 2024 4.60%
September 30, 2024 6.98%
June 30, 2024 4.81%
March 31, 2024 7.52%
December 31, 2023 2.03%
September 30, 2023 9.10%
June 30, 2023 25.14%
March 31, 2023 -5.52%
December 31, 2022 5.86%
September 30, 2022 6.45%
June 30, 2022 10.58%
March 31, 2022 11.54%
December 31, 2021 10.97%
September 30, 2021 16.54%
June 30, 2021 3.14%
March 31, 2021 14.87%
December 31, 2020 17.06%
September 30, 2020 10.83%
June 30, 2020 12.25%
Date Value
March 31, 2020 -2.89%
December 31, 2019 11.52%
September 30, 2019 9.36%
June 30, 2019 7.18%
March 31, 2019 14.13%
December 31, 2018 15.13%
September 30, 2018 17.35%
June 30, 2018 6.37%
March 31, 2018 23.43%
December 31, 2017 20.88%
September 30, 2017 21.51%
June 30, 2017 21.17%
March 31, 2017 19.47%
December 31, 2016 20.70%
September 30, 2016 22.38%
June 30, 2016 23.64%
March 31, 2016 21.21%
December 31, 2015 21.20%
September 30, 2015 22.06%
June 30, 2015 13.80%
March 31, 2015 14.93%
December 31, 2014 19.52%
September 30, 2014 14.27%
June 30, 2014 19.49%
March 31, 2014 18.49%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Cyanotech Corp. 42.38%
Mannatech, Inc. 75.90%
USANA Health Sciences, Inc. 74.91%
Nature's Sunshine Products, Inc. 70.84%
LifeVantage Corp. 77.97%

Gross Profit Margin (Quarterly) Related Metrics